Universitat de Girona-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

    The Lancet Respiratory Medicine, Vol. 5, Núm. 5, pp. 435-444